No Data
No Data
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
Harvard Bioscience Files $100 Million Mixed Shelf
Express News | Harvard Bioscience Inc Files for Mixed Shelf of up to $100 Mln - SEC Filing
Harvard Bioscience Third Quarter 2024 Earnings: Misses Expectations
Harvard Bioscience | 10-Q: Q3 2024 Earnings Report
12 Health Care Stocks Moving In Thursday's Intraday Session
No Data